Cara Therapeutics (CARA) Reports Ex-US Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma to Commercialize KORSUVA Injection
Tweet Send to a Friend
Cara Therapeutics, Inc. (NASDAQ: CARA) today announced that it has licensed worldwide rights, except in the U.S., Japan and South ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
